AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 49 filers reported holding AEVI GENOMIC MEDICINE INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,500,000 | $7,770,000 | 4.58% |
| Broadfin Capital, LLC | 3,370,306 | $17,458,000 | 1.94% |
| Casdin Capital, LLC | 375,000 | $1,943,000 | 1.60% |
| DLD Asset Management, LP | 555,000 | $2,880,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 450,000 | $2,331,000 | 0.59% |
| Worth Venture Partners, LLC | 119,000 | $211,000 | 0.23% |
| CARL DOMINO INC | 33,273 | $172,000 | 0.18% |
| Birchview Capital, LP | 48,000 | $249,000 | 0.15% |
| Perceptive Advisors | 293,460 | $1,520,000 | 0.11% |
| SIMON QUICK ADVISORS, LLC | 24,390 | $126,000 | 0.09% |